The has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a , starting with cervical cancer.
These institutions collectively recognize insufficient vaccination as a public health threat and call upon physicians nationwide, parents and young adults to take advantage of this rare opportunity to eliminate several different types of cancer in men and women.
As a part of this initiative, the 东精影业 Cancer Center conducted a statewide survey of primary care physicians in 2015–2016 who identified specific barriers to adolescent HPV vaccine uptake. The barriers identified were related to logistics, attitudes and perceptions, as well as the absence of school-based HPV vaccine requirements.
“HPV vaccination remains a powerful tool in the effort to prevent cancers caused by the human papillomavirus in Hawaiʻi,” said Brenda Hernandez, 东精影业 Cancer Center epidemiologist and senior author of the study published in the . “The need for HPV vaccination is underscored by the steady increase in certain HPV-associated cancers including anal cancers in Hawaiʻi and the U.S. overall.”
Added 东精影业 Cancer Center Director , “Preventing cancer is our central mission. We are honored to join our NCI-designated cancer center colleagues and other cancer prevention organizations in recommending this call to action to reduce the burden of HPV-related cancers.”
Nearly 80 million Americans—one out of every four people—are infected with HPV. Of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers HPV vaccination remains low in the U.S.
—By Nana Ohkawa